Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference164 articles.
1. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia;Li;N. Engl. J. Med.,2020
2. A novel coronavirus outbreak of global health concern;Wang;The Lancet,2020
3. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020
4. World Health Organization, 2020. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020.Internet] World Health Organization.
5. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;Chan;The Lancet,2020
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Protective Activity of Inactivated Rabies Vaccine Using Flagellin-Based Adjuvant;Биохимия;2024-09-14
2. The Development of Epitope-Based Recombinant Protein Vaccines against SARS-CoV-2;The AAPS Journal;2024-08-13
3. Protective Activity of Inactivated Rabies Vaccine Using Flagellin-Based Adjuvant;Biochemistry (Moscow);2024-03
4. Toll-Like Receptors and Emerging Viral Infections;Thirty Years since the Discovery of Toll-Like Receptors;2024-01-15
5. 30-Year Development of Inactivated Virus Vaccine in China;Pharmaceutics;2023-12-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3